[1]王 君,黄长明,吴 瑕,等.慢性阻塞性肺疾病患者血清内皮发育调节基因-1表达水平与炎症反应及疾病严重程度的相关性研究[J].现代检验医学杂志,2025,40(02):160.[doi:10.3969/j.issn.1671-7414.2025.02.030]
 WANG Jun,HUANG Changming,WU Xia,et al.Study on the Correlation between the Expression Level of Serum Developmental Endothelial Locus-1 and Inflammatory Response and Disease Severity in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2025,40(02):160.[doi:10.3969/j.issn.1671-7414.2025.02.030]
点击复制

慢性阻塞性肺疾病患者血清内皮发育调节基因-1表达水平与炎症反应及疾病严重程度的相关性研究()

《现代检验医学杂志》[ISSN:/CN:]

卷:
第40卷
期数:
2025年02期
页码:
160
栏目:
论著
出版日期:
2025-03-15

文章信息/Info

Title:
Study on the Correlation between the Expression Level of Serum Developmental Endothelial Locus-1 and Inflammatory Response and Disease Severity in Patients with Chronic Obstructive Pulmonary Disease
文章编号:
1671-7414(2025)02-160-05
作者:
王 君黄长明吴 瑕张 冉
(淮安市第五人民医院呼吸与危重症医学科,江苏淮安 223300)
Author(s):
WANG JunHUANG ChangmingWU XiaZHANG Ran
(Respiratory and Critical Care Medicine,Huai’an Fifth People’s Hospital,Jiangsu Huai’an 223300,China)
关键词:
慢性阻塞性肺疾病内皮发育调节基因-1炎症反应
分类号:
R563;R392.11
DOI:
10.3969/j.issn.1671-7414.2025.02.030
文献标志码:
A
摘要:
目的 探讨内皮发育调节基因-1(Del-1)与慢性阻塞性肺疾病(COPD)患者炎症反应以及疾病严重程度的关系。方法 选取淮安市第五人民医院在2023 年1 ~ 7 月收治的82 例COPD 患者作为COPD 组,并将其中40 例处于急性加重的患者纳入到急性加重组,将42 例处于稳定期的患者纳入到稳定组;另选取同期体检的健康志愿者40 例作为对照组。检测所有研究对象血清Del-1,C 反应蛋白(CRP)、白细胞介素-1β(IL-1β)以及中性粒细胞与淋巴细胞比值(NLR)的水平。采用Pearson 法分析血清Del-1 与炎症指标的相关性;采用受试者工作特征(ROC)曲线分析血清Del-1 对COPD 患者急性加重的预测价值。结果 COPD 组的血清CRP,IL-1β 以及NLR 水平均高于对照组(t=12.047,13.107,9.404),COPD 组血清Del-1 水平为386.87±42.34pg/ml,低于对照组的512.63±60.21pg/ml(t=13.343),差异具有统计学意义(均P<0.05);急性加重组的血清CRP,IL-1β 及NLR 水平均高于稳定组(t=4.170,5.292,5.919),急性加重组的血清Del-1 水平为347.64±40.69 pg/ml,低于稳定组(424.23±48.31 pg/ml)(t=7.746),差异具有统计学意义(均P<0.05)。经Pearson 分析显示,COPD 患者的血清Del-1 水平与血清CRP,IL-1β,NLR 水平均呈负相关(r=-0.534,-0.587,-0.612,均P<0.05);经ROC 分析显示,血清Del-1 对COPD 患者急性加重的预测价值较高,曲线下面积(95%CI)为0.886(0.812 ~ 0.960),取最佳截断值380.65 pg/ml 时,敏感度和特异度分别为82.50%,85.00%。结论 血清Del-1 在COPD 患者中呈现低表达,与患者的炎症反应及疾病严重程度呈负相关,有望成为预测COPD 急性加重风险的新型生物标志物。
Abstract:
Objective To explore the relationship between developmental endothelial locus-1 (Del-1) and inflammatory response and disease severity in patients with chronic obstructive pulmonary disease (COPD). Method 82 COPD patients admitted to Huai’an Fifth People’s Hospital from January 2023 to July 2023 were selected as the COPD group. Among them, 40 patients with acute exacerbation were included in the acute exacerbation group, and 42 patients in the stable phase were included in the stable group. Another 40 healthy volunteers who underwent physical examinations during the same period were selected as the control group. The levels of serum Del-1, C-reactive protein (CRP),interleukin-1β (IL-1β) and neutrophil to lymphocyte ratio (NLR) in all study subjects were detected. Pearson’s method was used to analyze the correlation between serum Del-1 and inflammatory markers. The predictive value of serum Del-1 for acute exacerbation in COPD patients was analyzed using receiver operating characteristic (ROC) curves. Result The serum CRP, IL-1β and NLR levels in the COPD group were higher than those in the control group (t=12.047,13.107,9.404), the serum Del-1 level in the COPD group was 386.87±42.34 pg/ml, lower than that in the control group 512.63±60.21 pg/ml (t=13.343),and the differences were statistically significant (all P<0.05). The serum CRP, IL-1β and NLR levels in the acute exacerbation group were higher than those in the stable group (t=4.170,5.292,5.919), the serum Del-1 level in the acute exacerbation group was 347.64±40.69 pg/ml, lower than that in the stable group 424.23±48.31 pg/ml (t=7.746),and the differences were statistically significant (all P<0.05). Pearson analysis showed that the serum Del-1 level in COPD patients were negatively correlated with serum CRP, IL-1β and NLR levels (r=-0.534,-0.587,-0.612,all P <0.05). ROC analysis showed that serum Del-1 had a high predictive value for acute exacerbation in COPD patients, with an AUC(95% CI) of 0.886 (0.812 ~ 0.960). When the optimal cutoff value was 380.65 pg/ml, the sensitivity and specificity were 82.50% and 85.00%, respectively. Conclusion Serum Del-1 is low expression in COPD patients and is ngeatively correlated with their inflammatory response and disease severity, it is expected to become a new biomarker for predicting the risk of acute exacerbation of COPD.

参考文献/References:

[1] RHEE C K. Chronic obstructive pulmonary disease research by using big data[J]. Clinical Respiratory Journal, 2021, 15(3): 257-263.
[2] RITCHIE A I, WEDZICHA J A. Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations [J]. Clinics in Chest Medicine, 2020, 41(3): 421-438.
[3] 张紫薇, 詹立睿, 李文, 等. 慢性阻塞性肺疾病急性加重风险预测模型的系统评价[J]. 中国呼吸与危重监护杂志,2022,21(9):622-628. ZHANG Ziwei, ZHAN Lirui, LI Wen, et al. Risk prediction model for acute exacerbation of chronic obstructive pulmonary disease:a systematic review [J]. Chinese Journal of Respiratory and Critical Care Medicine, 2022, 21(9): 622-628.
[4] LI Meng, ZHONG Di, LI Guozhong. Regulatory role of local tissue signal Del-1 in cancer and inflammation: a review[J].Cellular & Molecular Biology Letters, 2021, 26(1): 31.
[5] HENRION D. Modulating the immune response to reduce hypertension-associated cardiovascular damage[J]. Journal of Clinical Investigation, 2022, 132(6): e158280.
[6] IN?N? E, KAYIS S A, ESKAN M A, et al. Salivary Del-1, IL-17, and LFA-1 levels in periodontal health and disease[J].Journal of Periodontal Research, 2020, 55(4): 511-518.
[7] YAN Shu, CHEN Li, ZHAO Qi, et al. Developmental endothelial locus-1 (Del-1) antagonizes interleukin-17-mediated allergic asthma[J]. Immunology and Cell Biology, 2018, 96(5): 526-535.
[8] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组,中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021 年修订版)[J]. 中华结核和呼吸杂志,2021,44(3):170-205. Chronic Obstructive Pulmonary Disease Group of Chinese Thoracic Society,Chronic Obstructive Pulmonary Disease Committee of Chinese Association of Chest Physician. Guidelines for the diagnosis and management of chronic obstructive pulmonary disease(revised version 2021) [J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2021, 44(3): 170-205.
[9] FANG Liwen, GAO Pei, BAO Heling, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study [J]. the Lancet Respiratory Medicine, 2018, 6(6): 421-430.
[10] CHRISTENSON S A, SMITH B M, BAFADHEL M, et al. Chronic obstructive pulmonary disease[J]. Lancet, 2022, 399(10342): 2227-2242.
[11] 龙借帆, 李翠, 高元标, 等. 联合检测血清SIRT1 和CTRP5 水平对慢性阻塞性肺疾病急性加重期患者预后的预测价值研究[J]. 现代检验医学杂志,2022,37(3):162-166, 176. LONG Jiefan, LI Cui, GAO Yuanbiao, et al. Prognostic value of combined detection of serum SIRT1 and CTRP5 levels in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Journal of Modern Laboratory Medicine, 2022, 37(3): 162-166, 176.
[12] BRASSINGTON K, SELEMIDIS S, BOZINOVSKI S, et al. Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics[J]. Clinical Science (London, England : 1979), 2022, 136(6): 405-423.
[13] YE Chenglin, YUAN Li, WU Kailang, et al. Association between systemic immune-inflammation index and chronic obstructive pulmonary disease: a population-based study[J]. BMC Pulmonary Medicine, 2023, 23(1): 295.
[14] FAILER T, AMPONSAH-OFFEH M, NEUWIRTH A, et al. Developmental endothelial locus-1 protects from hypertensioninduced cardiovascular remodeling via immunomodulation[J].Journal of Clinical Investigation, 2022, 132(6): e126155.
[15] KOURTZELIS I, LI Xiaofei, MITROULIS I, et al. DEL-1 promotes macrophage efferocytosis and clearance of inflammation[J]. Nature Immunology, 2019, 20(1): 40-49.
[16] HAJISHENGALLIS G, CHAVAKIS T. DEL-1-regulated immune plasticity and inflammatory disorders[J]. Trends in Molecular Medicine, 2019, 25(5): 444-459.
[17] ZIOGAS A, MAEKAWA T, WIESSNER J R, et al. DHEA inhibits leukocyte recruitment through regulation of the integrin antagonist DEL-1[J]. Journal of Immunology, 2020, 204(5): 1214-1224.
[18] 张莹, 吴展陵, 涂平华. 不同炎症细胞表型在频繁发作的慢阻肺急性加重期患者中的临床特征差异[J].临床肺科杂志,2023,28(5):713-717, 731. ZHANG Ying, WU Zhanling, TU Pinghua. Clinical characteristics of different inflammatory cell phenotypes in patients with frequent AECOPD[J]. Journal of Clinical Pulmonary Medicine, 2023, 28(5): 713-717, 731.
[19] CIMINIERI C, WOEST M E, REYNAERT N L, et al. IL-1β induces a proinflammatory fibroblast microenvironment that impairs lung progenitors’ function [J]. American Journal of Respiratory Cell and Molecular Biology , 2023, 68(4): 444-455.
[20] KIM D Y, LEE S H, FU Yan, et al. Del-1, an endogenous inhibitor of TGF-β activation, attenuates fibrosis [J]. Frontiers in Immunology, 2020, 11: 68.

相似文献/References:

[1]邱淑佳.慢性阻塞性肺疾病患者血清LCN1,LCN2的表达水平及临床意义[J].现代检验医学杂志,2017,32(06):67.[doi:10.3969/j.issn.1671-7414.2017.06.001]
 QIU Shu-jia.Expression Levels of Serum LCN1 and LCN2 in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2017,32(02):67.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[2]杜 洁,朱 娜,李红艳,等.幽门螺杆菌感染对慢性阻塞性肺疾病血气分析及肺功能的影响[J].现代检验医学杂志,2017,32(06):99.[doi:10.3969/j.issn.1671-7414.2017.06.001]
 DU Jie,ZHU Na,LI Hong-yan,et al.Effect of Helicobacter Pylori Infection on Blood Gas Analysis and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2017,32(02):99.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[3]李若倩,刘 云,李若然.外周血红细胞分布宽度和超敏C- 反应蛋白水平检测在慢性阻塞性肺疾病诊断中的价值分析[J].现代检验医学杂志,2020,35(03):123.[doi:10.3969/j.issn.1671-7414.2020.03.033]
 LI Ruo-qian,LIU Yun,LI Ruo-ran.Value of Detecting Peripheral Blood Red Blood Cell Distribution Width and High Sensitivity C Reactive Protein in the Diagnosis of Chromic Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2020,35(02):123.[doi:10.3969/j.issn.1671-7414.2020.03.033]
[4]陈元菁,艾红军,王湘云,等.COPD 患者线粒体功能及代谢水平变化检测与骨骼肌功能障碍的相关性研究[J].现代检验医学杂志,2020,35(06):25.[doi:doi:10.3969/j.issn.1671-7414.2020.06.007]
 CHEN Yuan-jing,AI Hong-jun,WANG Xiang-yun,et al.Study on the Correlation between Changes Detection in Mitochondrial Function,Metabolic Level and Skeletal Muscle Dysfunction Inpatients with COPD[J].Journal of Modern Laboratory Medicine,2020,35(02):25.[doi:doi:10.3969/j.issn.1671-7414.2020.06.007]
[5]王 苗,张 萍.COPD患者血清 Cav-1及 CXCL12水平检测与并发肺动脉高压的相关性研究[J].现代检验医学杂志,2021,36(01):29.[doi:10.3969/j.issn.1671-7414.2021.01.008]
 WANG Miao,ZHANG Ping.Correlation between Levels of Cav-1 and CXCL12 in Serum and Pulmonary Hypertension in Patients with COPD[J].Journal of Modern Laboratory Medicine,2021,36(02):29.[doi:10.3969/j.issn.1671-7414.2021.01.008]
[6]闫海燕,杨云秀,杨云华,等.慢性阻塞性肺疾病患者 Nrf2 基因多态性与肺功能及临床病情判断的相关性研究[J].现代检验医学杂志,2021,36(03):27.[doi:10.3969/j.issn.1671-7414.2021.03.007]
 YAN Hai-yan1,YANG Yun-xiu2,YANG Yun-hua3,et al.Study on Relevance of Nrf2 Gene Polymorphism with Pulmonary Functionand Clinical Condition Judgment in Patients with Chronic ObstructivePulmonary Disease[J].Journal of Modern Laboratory Medicine,2021,36(02):27.[doi:10.3969/j.issn.1671-7414.2021.03.007]
[7]胡小燕,郑 晓,嵇华夏,等.血清 PCT 与 BNP 水平联合检测对慢性阻塞性肺疾病急性加重期并发心力衰竭的临床诊断价值[J].现代检验医学杂志,2021,36(03):128.[doi:10.3969/j.issn.1671-7414.2021.03.029]
 HU Xiao-yan,ZHENG Xiao,JI Hua-xia,et al.Clinical Diagnostic Value of Combined Detection of Serum PCT and BNPLevels in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated with Heart Failure[J].Journal of Modern Laboratory Medicine,2021,36(02):128.[doi:10.3969/j.issn.1671-7414.2021.03.029]
[8]陈志勇,罗世林,张 健,等.慢阻肺患者血清IL-17,IL-27和IL-33水平表达及与不同临床分期FeNO和肺功能的相关性研究[J].现代检验医学杂志,2021,36(04):152.[doi:10.3969/j.issn.1671-7414.2021.04.033]
 CHEN Zhi-yong,LUO Shi-lin,ZHANG Jian,et al.Expression of Serum IL-17, IL-27 and IL-33 in Patients with ChronicObstructive Pulmonary Disease and Its Correlation with FeNO and LungFunction in Different Clinical Stages[J].Journal of Modern Laboratory Medicine,2021,36(02):152.[doi:10.3969/j.issn.1671-7414.2021.04.033]
[9]王述红,邱 容,罗晓斌,等.慢性阻塞性肺疾病患者血气分析指标,FeNO,EOS%水平变化与CAT评分的相关性研究[J].现代检验医学杂志,2021,36(04):156.[doi:10.3969/j.issn.1671-7414.2021.04.034]
 WANG Shu-hong,QIU Rong,LUO Xiao-bin,et al.Correlation between Changes of Blood Gas Analysis Indexes, FeNO, EOS%and CAT Score in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2021,36(02):156.[doi:10.3969/j.issn.1671-7414.2021.04.034]
[10]龙借帆,李 翠,高元标,等.联合检测血清SIRT1和CTRP5水平对慢性阻塞性肺疾病急性加重期患者预后的预测价值研究[J].现代检验医学杂志,2022,37(03):162.[doi:10.3969/j.issn.1671-7414.2022.03.034]
 LONG Jie-fan,LI Cui,GAO Yuan-biao,et al.Prognostic Value of Combined Detection of Serum SIRT1 and CTRP5 Levels in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2022,37(02):162.[doi:10.3969/j.issn.1671-7414.2022.03.034]

备注/Memo

备注/Memo:
基金项目:江苏省卫生健康委科研项目(ZD2021023)。
作者简介:王君(1989-),女,本科,主治医师,研究方向:呼吸与危重症,E-mail:wangjun562314@126.com。
通讯作者:张冉(1990-),男,本科,主治医师,研究方向:呼吸与危重症医学科慢性阻塞性肺疾病,E-mail:1029900751@qq.com。
更新日期/Last Update: 2025-03-15